Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis

Alysha J Taxter1, E Paul Wileyto1, Edward M Behrens1

  • 1From the Department of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia; Center for Epidemiology and Biostatistics, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.A.J. Taxter, MD, Fellow, Department of Pediatric Rheumatology, The Children's Hospital of Philadelphia; E.P. Wileyto, PhD, Associate Professor, Center for Epidemiology and Biostatistics, The University of Pennsylvania; E.M. Behrens, MD, Associate Professor, Department of Pediatric Rheumatology, The Children's Hospital of Philadelphia; P.F. Weiss, MD, MSCE, Associate Professor, Department of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia.

The Journal of Rheumatology
|September 3, 2015
PubMed

Insights

Patients with enthesitis-related arthritis (ERA) and undifferentiated juvenile idiopathic arthritis (JIA) report worse pain, quality of life, and physical function. These findings highlight a need for targeted interventions for these JIA categories.

Area of Science:

  • Pediatric Rheumatology
  • Patient-Reported Outcomes
  • Juvenile Idiopathic Arthritis

Background:

  • Patient-reported outcomes (PRO) are increasingly vital for managing juvenile idiopathic arthritis (JIA).
  • Limited data exist on PRO variations across distinct JIA categories.
  • Understanding these differences is crucial for tailored disease management.

Purpose of the Study:

  • To evaluate patient-reported outcomes (PRO) including pain, quality of life, and physical function across JIA categories.
  • To identify clinical factors associated with disparities in PRO among JIA subtypes.
  • To inform strategies for improving PRO in pediatric rheumatology.

Main Methods:

  • Longitudinal cohort study design.
  • Data collected from a tertiary care pediatric rheumatology clinic's electronic medical records.
  • Mixed-effects regression analysis to assess PRO and clinical variables.

Main Results:

  • Enthesitis-related arthritis (ERA) and undifferentiated JIA categories reported significantly higher pain, poorer quality of life, and reduced physical function.
  • Factors associated with worse PRO included ERA and undifferentiated JIA categories, physician's global disease activity, female sex, and NSAID use.
  • In ERA-specific models, female sex and tender enthesis count predicted decreased function.

Conclusions:

  • Children with ERA and undifferentiated JIA experience inferior PRO compared to other JIA categories.
  • Further research is essential to develop interventions aimed at enhancing PRO in JIA patients.
  • Special attention should be directed towards improving outcomes for children with ERA and undifferentiated JIA.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
817
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.1K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
950